References
- Berry M. N., Friend D. S. High yield preparation of isolation rat liver parenchymal cells. Journal of Cell Biology 1969; 43: 506–520
- Bohacek N., Ravic M., Biziere K. A double-blind comparison of minaprine and- imipramine in the treatment of depressed patients. Journal of Clinical Psychopharmacology 1986; 6: 320–321
- Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976; 72: 248–254
- Davi H., Dupont P., Jeanniot J. P., Roncucci R., Cautrells W. The biotransformation of [14C]minaprine in man and five animal species. Xenobiotica 1981; 11: 735–747
- Davi H., Carayon A., Marti E., Sales Y., Cautreels W. Circulating and brain metabolites of minaprine in the baboon. Xenobiotica 1985; 15: 97–106
- Fabre G., Fabre I., Gewirtz D. A., Goldman D. Characteristics of the formation and membrane transport of 7-hydroxymethotrexate in freshly isolated rabbit hepatocytes. Cancer Research 1985; 45: 1086–1091
- Fabre G., Rahmani R., Placici M., Combalbert J., Covo J., Cano J. P., Coulange C., Ducros M., Rampal M. Characterization of midazolam metabolism using human hepatic microsomal fractions and hepatocytes in suspension obtained by perfusing whole human liver. Biochemical Pharmacology 1988; 37: 4389–4397
- Fong M. H., Abbiati A., Benfenati E., Caccia S. Quantitative analysis of minaprine and some of its metabolites with application to kinetic studies in rats. Journal of Chromatography 1983; 259: 141–149
- Guillouzo A., Begue J. M., Maurer G., Koch P. Identification of metabolic pathways of pindolol and fluperlapine in adult human hepatocytes cultures. Xenobiotica 1988; 18: 131–139
- Jouvent R., Lancrenon S., Patay M., Biziere K., Widlocher D. A controlled study of minaprine versus placebo in inhibited depressed out-patients. Minaprine, a New Psychotropic Drug Active in Affective Disorders, R. Dugay, P. Mandel. Sanofi Recherche, Montpellier 1984; 33–40
- Le Bigot J. F., Begue J. M., Kiechel J. R., Guillouzo A. Species differences in metabolism of ketotifen in rat, rabbit and man: demonstration of similar pathways in vivo and in cultured hepatocytes. Life Sciences 1987; 40: 883–890
- Mikus P., Biziere K., Bentel U. A controlled study of minaprine and nomifensine in outpatients with masked depression. Clinical Trials Journal 1985; 22: 477–488
- Necciari J., Bizien A., Bromet-Petit M., Berger Y. Pharmacokinetics of minaprine (CantorR) in the elderly. Intérét et Limites de la Pharmacocinétique en Recherche et Développement, J. Bres, G. Panis. Sauramps Medical, Montpellier 1988; 646–651
- Noguchi H., Okui M., Noda K., Sugiura M., Tanaka Y., Kato R. Species differences in metabolism of tiaramide hydrochloride, a new antiinflammatory agent. Xenobiotica 1977; 7: 505–512
- Omura T., Sato R. The carbon-monoxide binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2378
- Passeri M., Cucinotta D., De Mello M., Biziere K. Comparison of minaprine and placebo in the treatment of Alzheimer's disease and multi-infarct dementia. International Journal of Geriatric Psychiatry 1987; 2: 97–103
- Radmayr E., Biziere K., Bentel U. Minaprine and maprotiline in endogenous depression. A double-blind controlled study. Clinical Trials Journal 1986; 23: 100–109
- Van Der Hoven T. A., Coon M. J. Preparation and properties of partially purified cytochrome P450 and reduced nicotinamide adenine dinucleotide phosphate cytochrome P450 reduced from rabbit liver microsomes. Journal of Biological Chemistry 1974; 249: 6302–6310
- Ward C., Smith M. J., Hopkins R., Rogers H. J., Spector R. G., Robinson J. Clinical pharmacokinetics of minaprine. Toxicological Letters 1986; 31: 176, suppl
- Wermuth C. G., Exinger A. Le dichlorhydrate de la morpholinoethylamine-3 methyl-4 phenyl-6 pyridazine (Agr 1240). Agressologie 1972; 13: 285–289